EANS-Adhoc: The Management Board of CompuGroup Medical AG decides share buyback
09.07.2012 – 14:29
-------------------------------------------------------------------------------- ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. -------------------------------------------------------------------------------- 09.07.2012 The Management Board of CompuGroup Medical AG, Koblenz, ISIN DE0005437305 (the company), in accordance with Section 71 (1) 8 of the German Stock Corporation Act (Aktiengesetz), decided on July 9th, 2012 to make use of the authorization to buy back shares of the company granted by the shareholders at the annual general meeting on May 19th 2010. Up to 1,000,000 shares of the company will be repurchased, corresponding to approximately 1.88 percent of the company's share capital. The repurchased shares can be used for all purposes covered by the authorization of the annual general meeting. Shares will be repurchased exclusively through the XETRA trade of Deutsche Börse AG (Frankfurt Stock Exchange). The share buyback will be conducted in compliance with the terms of trade detailed in Article 5 of Commission Regulation (EC) No. 2273/2003 of December 22, 2003. The price the company pays per share is not allowed to exceed ten per cent more or less than the stock market price. The authoritative stock market price in this context is the non-weighted average price of the company's share which is determined by the closing auction in XETRA trading at Frankfurt Stock Exchange on the last five stock exchange trading days before the day when the shares are acquired. In addition to this, the shares will not be acquired at prices that are above the last independently made sale or, if it is higher, the last independent offer to buy the shares in XETRA trading at Frankfurt Stock Exchange. The share buyback will be executed by a credit institute which will decide on the time of the share's purchase independently and uninfluenced by the company. The share buyback will commence from July 9th 2012and will end April 30th , 2015 at the latest. The company's Management Board can decide to terminate the share buyback early at any time. Further inquiry note: Ralf Glass Vicepresident CEO support T +49 (0) 160 3630315 E-Mail: ralf.glass@cgm.com end of announcement euro adhoc -------------------------------------------------------------------------------- issuer: CompuGroup Medical AG Maria Trost 21 D-56070 Koblenz phone: +49 (0) 261 8000-0 FAX: +49 (0) 261 8000-1166 mail: investor@cgm.com WWW: www.cgm.com sector: Software ISIN: DE0005437305 indexes: stockmarkets: free trade: Berlin, München, Hamburg, Düsseldorf, Stuttgart, regulated dealing/prime standard: Frankfurt language: English